Beauty Health Co

For the period ended Dec 31, 2023. Filed Mar 12, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 12, 2024

SKIN$15.94-4.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Equity (Deficit

Common Stock · Additional Paid-in Capital · Note Receivable from Stockholder · Accumulated other Comprehensive Income (Loss) · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
BALANCE, December 31, 2020	35,501,743	$4	$13,952	$(554)	$242	$(44,211)	$(30,567)
Net loss	—	—	—	—	—	(378,764)	(378,764)
Issuance of Class A Common Stock in connection with business acquisitions	590,099	—	9,341	—	—	—	9,341
Issuance of earn-out shares	7,500,000	1	136,574	—	—	—	136,575
Issuance of Class A Common Stock pursuant to equity compensation plan	30,963	—	—	—	—	—	—
Shares withheld for tax withholdings on vested stock awards	(6,812)	—	—	—	—	—	—
Reverse recapitalization transaction, net	89,898,170	9	182,397	554	—	—	182,960
Purchase of capped calls related to Convertible Senior Notes	—	—	(90,150)	—	—	—	(90,150)
Issuance of Class A Common Stock in connection with the Warrant Redemptions	17,083,884	2	457,718	—	—	—	457,720
Share-based compensation	—	—	12,418	—	—	—	12,418
Foreign currency translation adjustment	—	—	—	—	(1,499)	—	(1,499)
BALANCE, December 31, 2021	150,598,047	$16	$722,250	$—	$(1,257)	$(422,975)	$298,034
Net income	—	—	—	—	—	44,224	44,224
Issuance of Class A Common Stock in connection with asset acquisition	28,733	—	500	—	—	—	500
Issuance of Class A Common Stock pursuant to equity compensation plan	409,565	—	—	—	—	—	—
Repurchase and retirement of Class A Common Stock	(18,759,243)	(2)	(159,998)	—	—	—	(160,000)
Equity forward contract in connection with accelerated share repurchase	—	—	(40,000)	—	—	—	(40,000)
Shares withheld for tax withholdings on vested stock awards	(62,407)	—	(927)	—	—	—	(927)
Share-based compensation	—	—	28,495	—	—	—	28,495
Foreign currency translation adjustment	—	—	—	—	(3,273)	—	(3,273)
BALANCE, December 31, 2022	132,214,695	$14	$550,320	$—	$(4,530)	$(378,751)	$167,053

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)(Continued)

Common Stock · Additional Paid-in Capital · Note Receivable from Stockholder · Accumulated other Comprehensive Income (Loss) · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
BALANCE, December 31, 2022	132,214,695	$14	$550,320	$—	$(4,530)	$(378,751)	$167,053
Net loss	—	—	—	—	—	(100,116)	(100,116)
Issuance of Class A Common Stock in connection with asset acquisition	109,625	—	1,310	—	—	—	1,310
Issuance of Class A Common Stock pursuant to equity compensation plan	1,039,176	—	—	—	—	—	—
Issuance of Class A Common Stock relating to employee stock purchase plan	241,342	—	3,036	—	—	—	3,036
Shares withheld for tax withholdings on vested stock awards	(355,087)	—	(3,234)	—	—	—	(3,234)
Accelerated share repurchase payment	—	—	(2,240)	—	—	—	(2,240)
Repurchase and retirement of Class A Common Stock	(10,350,749)	(2)	(30,455)	—	—	—	(30,457)
Share-based compensation	—	—	22,544	—	—	—	22,544
Foreign currency translation adjustment	—	—	—	—	1,494	—	1,494
BALANCE, December 31, 2023	122,899,002	$12	$541,281	$—	$(3,036)	$(478,867)	$59,390

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.